News About: Pharm. Industry
Main products of multinational pharmaceutical companies recorded poor performance on the 1st quarter
OTC drugs, strategically marketed by multinational pharmaceutical companies, have received poor sales performance.
Athlete’s foot and hand treatments, however, have only taken upturns.
According to the pharmaceutica...
Main products of multinational pharmaceutical companies recorded poor performance on the 1st quarter
OTC drugs, strategically marketed by multinational pharmaceutical companies, have received poor sales performance.
Athlete’s foot and hand treatments, however, have only taken upturns.
According to the pharmaceutica...
The government indicated 6 fields to adopt the Wage Peak System for the first time
The government, which has already adopted the Wage Peak System in public institutions, will push forward with the spread of the system as a part of alteration and support of the employment regulation.
The government ...
As Green Cross and SK will not launch tetravalent influenza vaccines, GSK is having the best time
As tetravalent influenza vaccines of Green Cross and SK Chemicals will not be launched in the 2015-2016 season, the domestic tetravalent influenza vaccine market is going to be taken over by GSK.
GSK is willing to re...
Less than a half of health functional food manufactures are GMP-proved companies
At this moment consumers are paying the highest attention to product quality, how many excellent health functional food manufacturers approved by the government, do you think, are there?
According to data unveiled re...
Visions created through the visit of ‘young leaders’ to big pharmaceuticals
Young leaders in the domestic pharmaceutical industry experienced the European market, then center of the global pharmaceutical market, in person. Owners and CEOs of domestic mid-sized pharmaceutical companies went of...
Boryung and Lilly will co-promote the pancreatic and lung cancer treatment ‘Gemzar’Boryung Pharmaceutical and Lilly Korea will jointly promote the pancreatic and lung cancer treatment ‘Gemzar.’
Boryung Pharmaceutical (President Tae-hong Choi) and Lilly Korea(...
|
Novartis and Yuhan Corporation will co-promote a new COPD complex‘Xoterna Breezhaler,’ the fixed capacity complex consisting of two bronchodilators, the long acting β2-agonist (LABA) indacaterol and the long-acting muscarinic antagonist (LAMA...
|
AstraZeneca Korea acquired an approval for the asthma and COPD inhaler ‘Symbicort Rapihaler’The AstraZeneca Korea’s(President Liz Chatwin) asthma and chronic obstructive pulmonary disease(COPD) treatment ‘Symbicort Rapihaler(budesonide + formoterol)’ has recently been ...
|
Despite the entry of the PCI/S, listed pharmaceutical companies
As joining the PIC/S(Pharmaceutical Inspection Co-operation Scheme), the domestic pharmaceutical industry was able to raise recognition of its pharmaceutical products in the international market, but their foreign exp...
